|
|
 |
|
Viewing report
|
|
|
|
Handbook of Pharmaceutical Biotechnology
Informa Healthcare, March 2003
Stay up to date with changes in the biopharmaceutical products market!With the growth rate of biopharmaceutical products ascending rapidly since the 1980s, the number of biotechnology companies has risen to more than 1200 new businesses in the Unites States alone. This dramatic increase creates a new set of challenges in education, putting demands on teachers and students to keep pace with innovations in terminology and techniques. The Handbook of Pharmaceutical Biotechnology is essential in meeting those challenges.A practical compendium of biotechnology-produced drugs, the Handbook of Pharmaceutical Biotechnology covers general principles of biotechnology and pharmaceuticals, putting usable information in the hands of those who need it most. The book presents descriptions that break down each pharmaceutical product by pharmacology, pharmacokinetics, clinical applications, toxicities, and dosage guidelines. It also reviews prescription products, discussing clinical uses and trials, adverse reactions, and more. Tables, figures, and extensive references add to each comprehensive summary.The Handbook of Pharmaceutical Biotechnology also includes up-to-date information on:
- monoclonal antibodies (Abciximab, Muromonab-CD3)
- enzymes and regulators of enzyme activity (Alteplase, clotting factors, Dornase alpha)
- anticytokines
- olgonucleotide and gene therapy
- hematopoietic growth factors (interleukins, interferons, colony stimulating factors, erythropoietin)
As the worldwide production and sales of biotechnology-derived pharmaceuticals and diagnostics continues to grow, teachers, students, and clinical pharmacists need to maintain a clear and current understanding of the field. The Handbook of Pharmaceutical Biotechnology presents a thoughtful and thorough guide to keeping pace in this evolving industry.
Customers who bought this item also bought
Pharmaceutical Biotechnology: Fundamentals and Applications, Third Edition
Growth Factors ( Blood And Tissue ) - Global Strategic Business Report
Do Emerging Therapies Offer Better Treatment Options for Hemophilia Patients?
Nitric Oxide - Therapeutics, Markets and Companies
Molecular Diagnostics - Technologies, Markets and Companies
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Growth Factors (Blood And Tissue) - Global Strategic Business Report
Future Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies
Immune Modulation Therapeutics
Dealmaking and Industry Outlook: Neurological Disease
|
|
|
|
